Tyme Technologies EV - Enterprise Value 2011-2026 | TYME

Annual EV - Enterprise Value Tyme Technologies

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-99 M	169 M	148 M	183 M	255 M	-6.11 M	853 M	86.8 K	-50 K	-14 K	-6.9 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
853 M	-99 M	137 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Keros Therapeutics KROS	261 M	$ 11.08	-1.47 %	$ 412 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	849 M	$ 216.97	-0.5 %	$ 5 B	Danmark
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	1.92 B	$ 19.25	0.1 %	$ 900 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
CollPlant Biotechnologies Ltd. CLGN	169 M	$ 0.67	10.54 %	$ 7.67 M	Israel
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.4	-0.36 %	$ 357 M	Britain
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	-15.2 M	$ 2.63	-	$ 16.5 M	USA
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Ligand Pharmaceuticals Incorporated LGND	2.26 B	$ 199.63	-0.36 %	$ 3.65 B	USA
Longeveron LGVN	16.9 B	$ 0.9	-5.5 %	$ 15.8 B	USA
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	847 M	$ 4.3	-2.83 %	$ 824 M	Canada
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Lixte Biotechnology Holdings LIXT	203 K	$ 2.65	-0.38 %	$ 5.08 M	USA
Calithera Biosciences CALA	916 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
Harmony Biosciences Holdings HRMY	1.26 B	$ 27.05	-1.99 %	$ 1.56 B	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA